NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News $154.98 -4.34 (-2.72%) As of 05/13/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FBT alerts:Sign Up Key Stats Today's Range$154.98▼$158.2150-Day Range$145.67▼$173.9852-Week Range$141.38▼$183.60Volume34,279 shsAverage Volume26,590 shsMarket Capitalization$1.02 billionAssets Under Management$1.02 billionDividend Yield0.75%Net Expense Ratio0.56%Aggregate RatingModerate Buy ETF OverviewThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.Read More… First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.57%0.57%0.52%0.53%Other Expenses0.16%0.30%0.48%0.56%0.52%Total Expense0.56%0.70%0.72%0.73%0.71%Fee Waiver0.00%-0.45%-0.49%-0.65%-0.54%Net Expense0.56%0.61%0.63%0.58%0.60% Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address FBT ETF News HeadlinesFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationApril 17, 2025 | uk.investing.comFirst Trust Announces Completion of MergersMay 6, 2024 | tmcnet.comURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the highest levels. But I believe a little-known coin could benefit even more—and I’ve revealed its name and ticker in a new briefing.May 14, 2025 | Paradigm Press (Ad)First Trust NYSE Arca Biotechnology Index Fund (FBT)March 31, 2024 | finance.yahoo.comClosing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)January 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)January 6, 2024 | theglobeandmail.comSee More Headlines FBT ETF - Frequently Asked Questions How have FBT shares performed this year? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $166.21 at the beginning of the year. Since then, FBT stock has decreased by 6.8% and is now trading at $154.98. View the best growth stocks for 2025 here. Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? First Trust NYSE Arca Biotechnology Index Fund's top institutional shareholders include LPL Financial LLC (2.81%), Raymond James Financial Inc. (2.39%), Envestnet Asset Management Inc. (1.76%) and Berger Financial Group Inc (1.69%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology Index Fund investors own include DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$1.02 billion Average Daily Volume$29,802.00 Discount/Premium-0.31% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableOptionable Options Volume4 Put Options5 Call Options4 Short Interest14,200 shs Miscellaneous Outstanding Shares6,550,000Beta0.70 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 FBT HoldingsBioNTech (NASDAQ:BNTX)Holding Weight: 3.93%Sarepta Therapeutics (NASDAQ:SRPT)Holding Weight: 3.80%Repligen (NASDAQ:RGEN)Holding Weight: 3.72%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 3.66%Beigene (NASDAQ:ONC)Holding Weight: 3.50%BioMarin Pharmaceutical (NASDAQ:BMRN)Holding Weight: 3.47%Genmab A/S (NASDAQ:GMAB)Holding Weight: 3.43%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 3.40%Exelixis (NASDAQ:EXEL)Holding Weight: 3.31%United Therapeutics (NASDAQ:UTHR)Holding Weight: 3.31%Full Holdings DetailsFBT Sector ExposureFBT Industry Exposure This page (NYSEARCA:FBT) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersAI Boom Takes a Shocking Turn…The AI “Gold Rush” is Here… History's repeating itself — but this time, the shovels are digital. Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Musk’s Next Big BetCancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.